Gufic BioSciences Ltd - GUFIC BIOSCIENCE Share Price

Sector: Pharmaceuticals | ISIN: INE742B01025
₹ 343.20 (-0.45%) icon18 May, 2024, 12:00:00 AM
Open
₹ 345.00
Prev. Close
₹ 344.75
Turnover(lac)
₹ 0.00
Day's High
₹ 348.00
Day's Low
₹ 338.25
52 Wk High
₹ 364.90
52 Wk Low
₹ 193.55
Book Value
₹ 51.25
Face Value
₹ 1.00
Mkt. Cap (Cr.)
₹ 3,441.52
P/E
40.91
EPS
8.40
Div. Yield
0.03

Gufic BioSciences Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/18/2024 12:00:00 AM

    ₹ 343.2 -1.55 -0.45
  • Open
  • ₹ 345
  • Prev. Close
  • ₹ 344.75
  • Turnover(Lac.)
  • ₹ 74
  • Day's High
  • ₹ 348
  • Day's Low
  • ₹ 338.25
  • 52 Week's High
  • ₹ 364.9
  • 52 Week's Low
  • ₹ 193.55
  • Book Value
  • ₹ 51.25
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 3,441.52
  • P/E
  • 40.91
  • EPS
  • 8.4
  • Divi. Yield
  • 0.03

Gufic BioSciences Ltd Corporate Actions

25 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2024

12:00 AM

02 Nov , 2023

12:00 AM

02 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Sep , 2023

12:00 AM

AGM

Announcement date: 01 Sep , 2023

View Details

27 Sep , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 May , 2023

12:00 AM

Dividend

Dividend amount: 0.1
Announcement date: 29 May , 2023

View Details

29 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Aug , 2023

12:00 AM

22 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Sep , 2023

12:00 AM

BookCloser

View Details

No Record Found


Gufic BioSciences Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Gufic BioSciences Ltd SHAREHOLDING SNAPSHOT
19 May , 2024 | 02:17 PM

PROMOTER - TOTAL72.51%

Indian: 72.51%

Foreign: 0%

NON-PROMOTER - TOTAL 27.49%

Institutions: 2.32%

Non-Institutions: 25.17%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Gufic BioSciences Ltd FINANCIALS

View Profit & Loss Graph

Gufic BioSciences Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Gufic BioSciences Ltd

  • Jayesh P Choksi
  • Chairman & Managing Director
  • Pranav J Choksi
  • Whole Time Director & CEO
  • Pankaj Gandhi
  • Whole-time Director
  • Shreyas Patel
  • Non-Exec. & Independent Dir.
  • Ami Naresh Shah
  • Company Sec. & Compli. Officer
  • Gopal Daptari
  • Non-Exec. & Independent Dir.
  • Shrirang V Vadiya
  • Non-Exec. & Independent Dir.
  • Balram Singh
  • Non-Exec & Non-Independent Dir
  • Rabi Narayan Sahoo
  • Non-Exec. & Independent Dir.
  • Anusanjiv Aurora
  • Non-Exec. & Independent Dir.
  • Dilip Ghosh
  • Whole-time Director

Summary

Gufic Biosciences (GBL) was incorporated in Jul84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a sellers market.... Read More


Reports by Gufic BioSciences Ltd


Reports by Gufic BioSciences Ltd

Company FAQ

No Record Found